Peter Explains the GLP-1 Agonists: Ozempic, Wegovy, Mounjaro, Zepbound, & Semaglutide

AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape - Peter Attia

0:00

1:23

0:00

1:23

AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape - Peter Attia

1 of 11

AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape - Peter Attia

1.0

Peter Explains the GLP-1 Agonists: Ozempic, Wegovy, Mounjaro, Zepbound, & Semaglutide

Clip Participants

Playback Speed

Share a link